Outline the biggest challenges presented to UCL's translational model when identifying high potential candidates
Discuss the role of academic research and translation in addressing the current pandemic environment, and the challenges inherent with timeline management
Analyse how changes in industry priorities and broader governmental support an be used to maximise the relationship between the academic and private sectors to fast-track viable therapies into development
How to balance safety, compliance and speed when qualifying raw materials for very different stem cell therapy purposes like cell banking or drug product manufacture for Clinical Phase I/II, Phase III or the Market?
Pernille Linnert Jensen
Senior Scientist - Project Lead Stem Cell R&D Novo Nordisk
Unsupported Browser Detected
The browser you are using is not supported that will prevent you from accessing certain features of the website. We want you to have the best possible experience. For this you'll need to use a supported browser and upgrade to the latest version.